77 related articles for article (PubMed ID: 31561368)
1. Neurotransmitter Imbalance in the Brain and Alzheimer's Disease Pathology.
Snowden SG; Ebshiana AA; Hye A; Pletnikova O; O'Brien R; Yang A; Troncoso J; Legido-Quigley C; Thambisetty M
J Alzheimers Dis; 2019; 72(1):35-43. PubMed ID: 31561368
[TBL] [Abstract][Full Text] [Related]
2. Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study.
Snowden SG; Ebshiana AA; Hye A; An Y; Pletnikova O; O'Brien R; Troncoso J; Legido-Quigley C; Thambisetty M
PLoS Med; 2017 Mar; 14(3):e1002266. PubMed ID: 28323825
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains.
Patel H; Hodges AK; Curtis C; Lee SH; Troakes C; Dobson RJB; Newhouse SJ
Brain Behav Immun; 2019 Aug; 80():644-656. PubMed ID: 31063847
[TBL] [Abstract][Full Text] [Related]
4. Disturbed neurotransmitter transporter expression in Alzheimer's disease brain.
Chen KH; Reese EA; Kim HW; Rapoport SI; Rao JS
J Alzheimers Dis; 2011; 26(4):755-66. PubMed ID: 21743130
[TBL] [Abstract][Full Text] [Related]
5. A Meta-Analysis of Alzheimer's Disease Brain Transcriptomic Data.
Patel H; Dobson RJB; Newhouse SJ
J Alzheimers Dis; 2019; 68(4):1635-1656. PubMed ID: 30909231
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.
Tandon R; Levey AI; Lah JJ; Seyfried NT; Mitchell CS
J Alzheimers Dis; 2023; 92(2):411-424. PubMed ID: 36776048
[TBL] [Abstract][Full Text] [Related]
7. A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.
Reddy PH
J Alzheimers Dis; 2017; 57(4):969-974. PubMed ID: 28409748
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic Transporters Serve as Potential Targets in Alzheimer's Disease.
Bist R; Bhatt DK
Curr Mol Med; 2024; 24(4):397-398. PubMed ID: 37151076
[TBL] [Abstract][Full Text] [Related]
9. The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons.
Sharma M; Pal P; Gupta SK
Brain Res; 2024 Apr; 1829():148797. PubMed ID: 38342422
[TBL] [Abstract][Full Text] [Related]
10. Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer's disease brain proteomic signature.
Roberts JA; Varma VR; Candia J; Tanaka T; Ferrucci L; Bennett DA; Thambisetty M
NPJ Aging; 2023 Jul; 9(1):18. PubMed ID: 37414805
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
[TBL] [Abstract][Full Text] [Related]
12. Systemic and central nervous system metabolic alterations in Alzheimer's disease.
van der Velpen V; Teav T; Gallart-Ayala H; Mehl F; Konz I; Clark C; Oikonomidi A; Peyratout G; Henry H; Delorenzi M; Ivanisevic J; Popp J
Alzheimers Res Ther; 2019 Nov; 11(1):93. PubMed ID: 31779690
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional Regulation of GABA
Kim HR; Martina M
Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38276272
[TBL] [Abstract][Full Text] [Related]
14. The function of previously unappreciated exerkines secreted by muscle in regulation of neurodegenerative diseases.
Bian X; Wang Q; Wang Y; Lou S
Front Mol Neurosci; 2023; 16():1305208. PubMed ID: 38249295
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease: the role of extrinsic factors in its development, an investigation of the environmental enigma.
Suresh S; Singh S A; Rushendran R; Vellapandian C; Prajapati B
Front Neurol; 2023; 14():1303111. PubMed ID: 38125832
[TBL] [Abstract][Full Text] [Related]
16. Recent progress of nanomedicine in the treatment of Alzheimer's disease.
Hu L; Tao Y; Jiang Y; Qin F
Front Cell Dev Biol; 2023; 11():1228679. PubMed ID: 37457297
[TBL] [Abstract][Full Text] [Related]
17. Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?
Yin C; Harms AC; Hankemeier T; Kindt A; de Lange ECM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902391
[TBL] [Abstract][Full Text] [Related]
18. A high performance liquid chromatography tandem mass spectrometry protocol for detection of neurotransmitters in the rat brain tissue.
Dai D; Qin Q; Zhu X; Fang Q; Meng X; Bai L; Yang G; Shan L; Liu C
MethodsX; 2023; 10():102083. PubMed ID: 36875344
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging studies of acupuncture on Alzheimer's disease: a systematic review.
Yin Z; Wang Z; Li Y; Zhou J; Chen Z; Xia M; Zhang X; Wu J; Zhao L; Liang F
BMC Complement Med Ther; 2023 Feb; 23(1):63. PubMed ID: 36823586
[TBL] [Abstract][Full Text] [Related]
20. Increased functional connectivity patterns in mild Alzheimer's disease: A rsfMRI study.
Penalba-Sánchez L; Oliveira-Silva P; Sumich AL; Cifre I
Front Aging Neurosci; 2022; 14():1037347. PubMed ID: 36698861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
